Saga is a net of consultants with vast hands-on experience in biotechnology industry. Saga members have worked in different roles in the biopharma industry. This knowledge is key factor.
The new era (post COVID) challenges are still beyond full understanding, never before have a pandemic has been resolved to the point of obtaining multiple vaccines and therapeutic treatments in less than two years, the responds from governments and privet sector easily exceeds the 2020-20XX landscape capabilities. The more notable limitations since COVID begging (late 2019) were the materials resources and production footprints. Both challenges are in the scope and current plans of the lead companies for supply’s (thermo Fisher, Avantor, Cytiva, Pall, Millipore) and operations (CDMO, CMO, and traditional MFG). These big pharma solutions creates the perfect scenario for SAGA’s origin: “With that many new facilities and low chances to fail, the future of any company need to be run by capable and knowable people” Being this the ultimate meaning of SAGA, to deliver success.
Human Resource in the biotech industry is becoming a currency and a success indicator. Besides the scarcity personnel, HR quality and knowledge are questionable in many cases. Companies for the mere fact of obtaining the new HR currency are always at race and employee work experiences are averaging less than never at the bigger US biotech hubs. In addition, having 24/7 human resources available to satisfy company goals (process surveillance, development scientists, quality experts, tech transfer engineers, etc) have never been more needed due the big number of new companies and projects, the pool of talented people just got diluted.
The Single-Use revolution and the process simplification (automation, resin technologies, softwares, integration, etc), degree for the 2020 decade in the biotech field have caused also an impact in the new biotech HR waves, biotech professionals are no longer exposed to traditional fermenters and downstream (chromatography, TFF, etc) systems, this new simplicity impacts the skill box for the new employee and the not that new generation is becoming less abundant.
Finally, after many interactions and experiences with new and established MFG engineers and PD scientist, it is detected that the education centers require more oriented industry activities. The SAGA proposal goes beyond the current educational scheme allowing an easy access to the most notable technologies and the clearest way to be prepared for a professional begging at the Biotech Industry.
Flexibility
Quality
Knowledge
Dedication
Passion